Easy to use, more effective and cheap, nasal Covid vaccines can be game changer: scientists

Earlier this month, Bharat Biotech announced that its iNCOVACC (BBV154),the world's first intranasal COVID-19 vaccine, has received approval from the Drugs Controller General of India for restricted use in emergencies for those 18 and older. The vaccine is yet to be marketed.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/L8XEnjG
via IFTTT